10 Small Cap Stocks with High Potential
As we transition from a tumultuous summer in the financial markets, characterized by rising expectations for interest rate cuts and the consequent impacts on stock and bond performances, investors are...
Centessa Pharmaceuticals Plc (CNTA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Perceptive Advisors Joseph Edelman | 6,282,290 | $100,453,817 | +60% | 2.12% |
| 2. | Adage Capital Management Phill Gross And Robert Atchinson | 4,195,000 | $67,078,050 | +35% | 0.11% |
| 3. | EcoR1 Capital Oleg Nodelman | 3,223,851 | $51,549,377 | -44% | 1.76% |
| 4. | Farallon Capital Thomas Steyer | 2,814,318 | $45,000,945 | +41% | 0.22% |
| 5. | Point72 Asset Management Steve Cohen | 2,715,663 | $43,423,451 | +55% | 0.11% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.63 | 10,000 | Officer, Director | 38,000 | 2022-06-24 | Filing | |
| $9.74 | 5,000 | Officer, Director | 28,000 | 2022-02-02 | Filing | |
| $9.05 | 27,500 | Officer | 27,500 | 2022-01-28 | Filing | |
| $12.82 | 796 | Director | 93,526 | 2021-12-02 | Filing | |
| $12.82 | 33,530 | Director | 3,936,970 | 2021-12-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.28 | 32,023 | Officer, Director | 630,661 | 2024-11-13 | Filing | |
| $15.38 | 11,742 | Officer | 183,266 | 2024-10-25 | Filing | |
| $15.32 | 2,592 | Officer, Director | 630,661 | 2024-10-23 | Filing | |
| $15.67 | 30,203 | Officer, Director | 633,253 | 2024-10-22 | Filing | |
| $15.80 | 22,205 | Officer, Director | 663,456 | 2024-10-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 19,963,157 | $158,906,730 | 53.64% | |
| 2. | 9,681,818 | $77,067,271 | 1.1% | |
| 3. | 3,931,818 | $31,297,271 | 37.25% | |
| 4. | 2,787,194 | $22,186,064 | 0% | |
| 5. | 2,040,816 | $16,244,895 | 1.8% |
News See All
10 Best Biotech Stocks To Buy Under $20
The biotechnology industry is experiencing rapid growth, driven by increasing demand for innovative treatments, technological advancements, and government support.
Top 10 Stock Picks of Srini Akkaraju and Michael Dybbs' Samsara BioCapital
In this article, we discuss the top 10 stock picks of Srini Akkaraju and Michael Dybbs' Samsara BioCapital.
15 Biotech Stocks to Buy Now According to Srini Akkaraju and Michael Dybbs' Samsara BioCapital
In this article, we will discuss 15 biotech stocks to buy now according to Srini Akkaraju and Michael Dybbs' Samsara BioCapital.
Billionaire Hedge Funds
